ABOUT HIRAY

Let's connect


Learn how Hiray Pharma shares their proprietary technology with you.

Registration

Recommendation

Public Notice of Environmental Protection Acceptance of Project 103 of Hiray Pharmaceutical (Jingmen) Co.

2023/09/05

Public Notice of Environmental Protection Acceptance of Project 103 of Hiray Pharmaceutical (Jingmen) Co.

View Details

Recommendation

Professor P. Andrew Evans of Queen University of Canada was invited to give an academic lecture in Hiray Pharma(Jingmen)

2023/05/26

On May 23rd, 2023, Hiray Pharma (Jingmen) Solutions Ltd. held an academic lecture on synthetic chemistry in the HIRAY TALK area on the first floor of the quality inspection building. The theme of this lecture is "challenging C- C- bond three-dimensional selection structure and total synthesis of toxic carotene". Professor P. Andrew Evans from Queen University of Canada is specially invited to attend for academic exchange.

View Details

Recommendation

Lecture on "HIRAY Synthetic Chemistry Academic Lecture" at School of Chemistry and Molecular Science, Wuhan University

2023/03/20

On March 17, 2023, when the cherry blossoms of Wuhan University were in full bloom, the Fifth Cherry Blossom Forum on Organic Chemistry of Wuhan University arrived as scheduled, and chemists from all over the country gathered at Wuhan University. During the same period, Professor Zhang Xumu gave the first lecture on "Hiray Synthetic Chemistry Academic Lecture" jointly established by Hiray Pharma (Jingmen) and the School of Chemistry and Molecular Science of Wuhan University. The topic of this lecture is "Application of Multidentate Chiral Ligands in Efficient Asymmetric Hydrogenation". Mr. Chen Ya, Chairman of Haite Biology and Hiray Pharma (Jingmen), served as the moderator of this lecture. The "Hiray Academic Lecture on Synthetic Chemistry" project lasts for 3 years, with 36 lectures each month. Famous experts and professors will be invited to give lectures in each issue, aiming to lead the cutting-edge technology of "learning, research, and production" in the chemical industry, and promote the integration of academia, research, and industry.

View Details

Recommendation

Good News | HIRAY Pharmaceutical (Jingmen) was listed in "2022 Top 20 Chinese Pharmaceutical CDMO Enterprises"

2023/03/16

This morning (December 9), Yaozhi.com and China Pharmaceutical Magazine jointly held the "2022 High Quality Development Conference of the Health Industry and the 7th China Pharmaceutical Research and Development • Innovation Summit" online. At the meeting, the "2022 China Pharmaceutical Research and Development Strength Ranking Series List" was solemnly released, and Hanrui Pharmaceutical (Jingmen) was listed in the "2022 China Pharmaceutical CDMO Enterprise Top 20".

View Details